TL-HEM 150

Manufacturer
Trigen Laboratories, LLC
Effective date
2022-01-20
Label type
DIETARY SUPPLEMENT
Version
5
Source
legacy-cache
Hydrated at
2026-08-01 22:11:27

Label at a glance#

ProductTL-HEM 150
Active ingredientASCORBIC ACID, .ALPHA.-TOCOPHEROL ACETATE, DL-, FOLIC ACID, CYANOCOBALAMIN, BIOTIN, IRON, CUPRIC SULFATE, DOCUSATE SODIUM
Label structure11 sections

Dosage and administration

Usual adult dose is one caplet daily or as prescribed by a physician.

Label contents#

Full prescribing information#

SUPPLEMENT FACTS TABLE

STATEMENT OF IDENTITY SECTION

Supplement Facts Panel
Supplement Facts Panel

Other Ingredients: Microcrystalline Cellulose, Coating (Polyvinyl Alcohol, Titanium Dioxide, Polyethylene Glycol, Talc, FD&C Yellow #6 Lake, FD&C Blue #2 Lake), Tripotassium Citrate, Citric Acid, Povidone K30, Acacia, Stearic Acid, Fumed Silica, and Magnesium Stearate.


TL-HEM 150 is a hematinic multivitamin/multimineral dietary supplement used to improve the nutritional status of patients with iron deficiency.

CONTRAINDICATIONS

HEALTH CLAIM SECTION

This product is contraindicated in patients with a known hypersensitivity to any of the components of this product. Hemochromatosis and hemosiderosis are contraindications to iron therapy.

WARNINGS

WARNINGS SECTION

WARNING: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. KEEP THIS PRODUCT OUT OF REACH OF CHILDREN.  In case of Accidental overdose, call a doctor or poison control center immediately.

PRECAUTIONS

PRECAUTIONS SECTION

General: Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where vitamin B12 is deficient. Folic acid in doses above 1.0 mg daily may obscure pernicious anemia in that hematologic remission can occur while neurological manifestations remain progressive. Do not exceed recommended daily dose. Some patients affected with pernicious anemia may not respond to orally administered Vitamin B12 with intrinsic factor concentrate and there is no known way to predict which patients will respond. Periodic clinical assessment of pernicious anemia patients by a physician are recommended. If any symptoms of intolerance to TL-HEM 150, including but not limited to nausea, vomiting, abdominal cramps or rash occur, the drug should be discontinued, as determined by a physician.


Biotin levels higher than the recommended daily allowance may cause interference with some laboratory tests, including cardiovascular diagnostic tests (e.g. troponin) and hormone test, and may lead to incorrect test results. Tell your healthcare provider about all prescription and over-the-counter medicines, vitamins, and dietary supplements that you take, including biotin.


Pediatric Use:
Safety and effectiveness in pediatric patients have not been established.


Geriatric Use: Safety and effectiveness in elderly patients have not been established.

ADVERSE REACTIONS

HEALTH CLAIM SECTION

Adverse reactions with iron therapy may include constipation, diarrhea, nausea, vomiting, dark stools and abdominal pain. Skin rashes of various types may occur. Such reactions may necessitate temporary or permanent changes in dosage or usage. Allergic sensitization has been reported following both oral and parenteral administration of folic acid.

DESCRIPTION

STATEMENT OF IDENTITY SECTION

TL-HEM 150 caplets are oval, beige, film-coated caplets debossed “TL606”.

DIRECTIONS FOR USE

HEALTH CLAIM SECTION

Usual adult dose is one caplet daily or as prescribed by a physician.

HOW SUPPLIED

HEALTH CLAIM SECTION

TL-HEM 150 is supplied in bottles of 90 caplets.

PRODUCT CODE 13811-609-90

STORAGE

SAFE HANDLING WARNING SECTION

Store at 20°-25°C (68°-77°F), excursion permitted to 15°-30°C (59°-86°F) [See USP Controlled Room Temperature].

HEALTH CLAIM SECTION

KEEP OUT OF REACH OF CHILDREN.

For use on the order of a healthcare practitioner.

Call your doctor about side effects. To report side effects, call Trigen Laboratories at 1-888-9-TRIGEN (1-888-987-4436) or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

Customer Service: 1-888-987-4436                             Rev. 07/2018

Manufactured for:

Trigen Laboratories, LLC

Bridgewater, NJ 08807

TRIGEN LOGOTRIGEN LOGO

PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

TL-HEM 150

NDC 13811-609-90

90 Count

Rev072018Rev072018

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
13811-609-90EA - Each13811-6090ac3109c-d7a4-4ab9-8d5d-0d1084453b5312018-06-11

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 27 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
13811-60913811-609-90

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 22 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 4 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Ascorbic AcidASCORBIC ACIDRenova Pharmaceuticals LLCa6481bae-2397-44c7-a51d-4f47ad91bd2c2026-08-19Warnings, Adverse reactionsName fallback
generic name: ASCORBIC ACID
AscorASCORBIC ACIDMcGuff Pharmaceuticals, Inc.388aad52-fc01-4784-9791-1dbc80c693062026-05-29Warnings, Adverse reactionsName fallback
generic name: ASCORBIC ACID
Ascorbic AcidASCORBIC ACIDFresenius Kabi USA, LLC1606e29f-0e80-4069-b688-daab9cbff20a2025-12-17Warnings, Adverse reactionsName fallback
generic name: ASCORBIC ACID
Skin Renewing SerumASCORBIC ACIDGuangzhou Danting Bath&Body Care Industry Co. Ltd396c2a8d-ac95-cbef-e063-6294a90aff392025-08-23WarningsName fallback
generic name: ASCORBIC ACID

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.